Dr. Wu Ke is the President and Founder of Shanghai BravoBio Co., Ltd. He has 23 years of experiences in biopharm industry and had successfully developed 7 products which were approved by SFDA and marketed in China.
Dr. Wu Ke was Executive President of Shanghai Zerun Biotechnology Co., Ltd., in charge of management of QA/QC, Manufacture, Engineering and Maintenance, Regulatory Affairs, Marketing and Sales, also extensively experienced in R&D management, business development, technology transfer, facility evaluation, etc. Prior to joining Zerun/Wison in 2004, Dr. Wu Ke was Director of R&D in Wuhan Institute of Biological Products (WIBP) of China National Biotec Group (CNBG). He was department manager of Blood Products, department manager of Cell Biology and project manager for Tumor Biology in WIBP.
He holds a BA degree in Biochemistry and a PhD degree in Immunology. He also has Certificates of Senior Management from China Europe International Business School (CEIBS) and Cheung Kong Graduate School of Business (CKGSB).